Frankfurt - Delayed Quote EUR
Insmed Incorporated (IM8N.F)
59.00
-5.00
(-7.81%)
As of 3:44:07 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 13 | 16 | 16 |
| Avg. Estimate | 92.09M | 103.78M | 467.83M | 1B |
| Low Estimate | 86.8M | 99.8M | 441.4M | 806.2M |
| High Estimate | 103M | 109M | 512.3M | 1.41B |
| Year Ago Sales | 75.5M | 90.34M | 363.71M | 467.83M |
| Sales Growth (year/est) | 21.97% | 14.88% | 28.63% | 114.08% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IM8N.F | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/22/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/20/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 3/19/2025 |
| Maintains | UBS: Buy to Buy | 3/6/2025 |
| Initiated | RBC Capital: Outperform | 2/25/2025 |
| Reiterates | Guggenheim: Buy to Buy | 2/25/2025 |